EIisa –a connected, affordable light solution for treating sleep apnea.

Informazioni relative al progetto

SUNRISE Tx

ID dell’accordo di sovvenzione: 190180051

DOI

10.3030/190180051

Progetto chiuso

Data della firma CE 29 Giugno 2022

Data di avvio 1 Luglio 2022

Data di completamento 31 Dicembre 2024

Finanziato da

• The European Innovation Council (EIC)

Costo totale

€ 2 771 250,78

Contributo UE

€ 1 939 875,00

Coordinato da

SUNRISE
Belgium

Periodic Reporting for period 2 - SUNRISE Tx (EIisa –a connected, affordable light solution for treating sleep apnea.)

Periodo di rendicontazione: 2023-07-01 al 2024-12-31

Sintesi del contesto e degli obiettivi generali del progetto

Sleep apnea is a common sleep disorder characterized by repeated interruptions in breathing during sleep. It is a major comorbidity of cardiovascular disease and a significant risk factor for type 2 diabetes, stroke, coronary artery disease, congestive heart failure, and atrial fibrillation, among other conditions. The current gold standard treatment relies on positive airway pressure (PAP) devices, which often cause discomfort, as they require patients to wear a face mask connected to a hose throughout the night. The Sunrise Tx project introduces the first truly comfortable, non-invasive, cost-effective, and accessible solution for sleep apnea treatment. Sunrise Tx is designed to broaden access to personalized therapy, improve patient compliance, and provide millions of people worldwide with a more comfortable and effective solution for managing their sleep apnea.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

The activities focused on refining the design and enhancing patient comfort for the Sunrise Tx device. Through extensive research and multiple design iterations, significant advancements were achieved, resulting in a markedly improved user experience. A rigorous clinical validation process was implemented to thoroughly assess the device’s efficacy and safety. The validation results demonstrated strong clinical value, earning widespread support from the medical community.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The Sunrise Tx project surpasses the current state of the art in sleep apnea treatment by offering a non-invasive, cost-effective, and patient-centered solution that overcomes the limitations of conventional PAP therapies. Building on its validated efficacy and safety, the device integrates innovative design and personalized therapy to significantly enhance comfort, usability, and patient compliance, addressing key barriers to long-term adherence. Beyond improving the user experience, Sunrise Tx expands access to effective care, providing a practical and scalable solution for millions of patients. By combining technological innovation with a patient-centric approach, Sunrise Tx represents a transformative advancement in sleep apnea management, setting a new standard in therapeutic care.

SUNRISE logo